# Living Water Peptides — Longevity & Cellular Health Research Peptides > Living Water Peptides is a reference desk for Longevity & Cellular Health research — NAD+ and MOTS-c — summarized from peer-reviewed literature. A digest, not a vendor or clinic. A data-forward reading desk for the published science on NAD+ and MOTS-c — what each was actually studied for, in which species, and how strong the evidence really is. ## The short version Living Water Peptides is a reading desk, not a store. It collects what the published research literature actually says about two molecules that keep appearing in conversations about **longevity and cellular health**: NAD+ and MOTS-c. A *peptide* is a short chain of amino acids — the same building blocks as proteins, only smaller. MOTS-c is a true peptide, just 16 amino acids long. NAD+ is not a peptide at all; it is a *coenzyme*, a small molecule the cell uses to transfer electrons during energy production. They appear here together because they share a theme: both are understood through the lens of mitochondrial biology and metabolic aging. This desk does one job: it tells you, in plain language and with citations, what each molecule was tested on, in which species, and how far that evidence really reaches. For NAD+ precursors, human evidence exists and is growing — though its translation to long-term clinical outcomes remains an open question. For MOTS-c, the evidence is largely from animals. Neither is an approved medicine for longevity. This site does not sell anything, gives no medical advice, and lists no human dose. ## What are research peptides? Proteins in your body — a structural fiber in your muscle, a hormone, an enzyme — are long chains of amino acids folded into a working shape. A *peptide* is a much shorter chain of the same amino acids, sometimes only a few links long. Because they are small and specific, peptides can act like keys that fit particular receptor-locks on cell surfaces, switching certain processes on or off. A *research peptide* is one that has been synthesized and studied in the laboratory — in cell cultures, animals, occasionally early human pilots — but has **not** been approved by a regulator as a medicine. Sellers describe these compounds as being for laboratory research only, and that framing matters: it means dosing, long-term safety, and real-world effectiveness in people are usually unestablished. When this site reports a number, it reports it exactly as the study did — for example, *studied at 5 mg/kg in mice* — never as a recommendation. Where a molecule derives from a natural endogenous source, this desk says so, because that lineage is often the key to understanding its mechanism. ## How these two fit into longevity and cellular-energetics research NAD+ and MOTS-c approach cellular aging from complementary angles, which is why they sit together on this desk. - [**NAD+**](/nad) is the lead. It is not a peptide but the cell's central *redox coenzyme* — a molecule that carries electrons through glycolysis, the TCA cycle, and oxidative phosphorylation to produce ATP — and also a substrate consumed by signaling enzymes (sirtuins, PARPs, CD38) that govern DNA repair and inflammation [4]. NAD+ levels fall with age, partly because the enzyme CD38 rises with age and consumes it [6]. Human trials with precursors such as NMN and NR have consistently raised blood NAD+, though a 2025 review concluded translation to hard clinical endpoints remains inconsistent and tissue-specific data sparse [1]. - [**MOTS-c**](/mots-c) is a 16-amino-acid peptide encoded within the mitochondrial genome's 12S rRNA gene — the first mitochondrially encoded peptide shown to translocate to the nucleus and regulate nuclear gene expression [12]. Its primary mechanism runs through AMPK activation, and exogenous MOTS-c improved physical performance across young, middle-aged, and old mice in a 2021 Nature Communications study [11]. Human data are observational biomarker associations, not interventional outcomes. Together they sketch cellular aging from two sides: the metabolic-currency angle (NAD+) and the mitochondrial-signaling angle (MOTS-c). Use the directory to read each one, or [compare these two](/compare) side by side. ## A note on how this desk reads the literature Living Water Peptides is a cross-referenced literature digest. Each page summarizes the peer-reviewed studies for that molecule, cites them by number, and links to a single shared [references list](/references) aggregating every source. Where the evidence is thin, single-lab, or preclinical only, this desk says so plainly — that caution is part of the record, not a footnote to it. Effect sizes, study designs, and sample sizes are reported because they are what distinguish a robust signal from a preliminary one. The aim is an accurate, data-forward map of what is known, so you can see where the science is solid and where it is still early promise. --- A data-forward digest of peer-reviewed cellular-energetics research — effect sizes and study designs, not supplements and not prescriptions.